Huntington's disease: the new gene therapy that sufferers cannot afford

In September last year researchers led by Professor Sarah Tabrizi (UCL Institute of Neurology) began the human testing of a drug that, if successful, would be the first to slow down the progression of Huntington's disease. Read: Guardian